Edgestream Partners L.P. purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 31,790 shares of the company’s stock, valued at approximately $7,073,000.
A number of other large investors have also bought and sold shares of CAH. BlackRock Inc. bought a new stake in shares of Cardinal Health in the second quarter valued at approximately $6,293,115,000. Wellington Management Group LLP lifted its stake in Cardinal Health by 247.5% in the 2nd quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after purchasing an additional 10,584,119 shares in the last quarter. Bank of America Corp DE purchased a new stake in Cardinal Health in the 2nd quarter worth approximately $689,066,000. Legal & General Group Plc bought a new position in Cardinal Health in the 2nd quarter valued at $438,870,000. Finally, Pacer Advisors Inc. boosted its holdings in Cardinal Health by 14.7% in the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company’s stock valued at $330,728,000 after purchasing an additional 200,021 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on CAH shares. Royal Bank Of Canada boosted their price target on shares of Cardinal Health from $276.00 to $295.00 and gave the company an “outperform” rating in a research report on Friday, November 6th. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 25th. UBS Group lifted their price objective on Cardinal Health from $280.00 to $295.00 and gave the company a “buy” rating in a research note on Friday, October 16th. Citigroup boosted their target price on Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. Finally, Morgan Stanley upped their target price on Cardinal Health from $265.00 to $286.00 and gave the stock an “overweight” rating in a research note on Friday, October 30th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $287.13.
Cardinal Health Price Performance
Shares of Cardinal Health stock opened at $279.29 on Wednesday. Cardinal Health, Inc. has a 1 year low of $180.45 and a 1 year high of $286.29. The firm has a market cap of $64.55 billion, a PE ratio of 36.13, a PEG ratio of 2.17 and a beta of 0.53. The company has a 50 day simple moving average of $245.68 and a two-hundred day simple moving average of $225.95.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $3.26 EPS for the quarter, topping analysts’ consensus estimates of $2.94 by $0.32. The firm had revenue of $67.51 billion for the quarter, compared to analyst estimates of $66.67 billion. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.55 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 12.97 earnings per share for the current year.
Cardinal Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be given a $0.5158 dividend. The ex-dividend date is Monday, January 4th. This represents a $2.06 annualized dividend and a yield of 0.7%. Cardinal Health’s payout ratio is 26.65%.
About Cardinal Health
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
Featured Stories
- Five stocks we like better than Cardinal Health
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
